Bridget E. Bunner

Array ( [id] => 7697065 [patent_doc_number] => 20110229525 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-22 [patent_title] => 'MODULATION OF CYTOKINE SIGNALING' [patent_app_type] => utility [patent_app_number] => 13/047495 [patent_app_country] => US [patent_app_date] => 2011-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 22935 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20110229525.pdf [firstpage_image] =>[orig_patent_app_number] => 13047495 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8371365 [patent_doc_number] => 20120220755 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-30 [patent_title] => 'ORGANIC CATION TRANSPORTER POLYPEPTIDES' [patent_app_type] => utility [patent_app_number] => 13/047399 [patent_app_country] => US [patent_app_date] => 2011-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 9057 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13047399 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9059651 [patent_doc_number] => 08546086 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-01 [patent_title] => 'Use of neuregulin-β as an indicator and/or target' [patent_app_type] => utility [patent_app_number] => 13/035352 [patent_app_country] => US [patent_app_date] => 2011-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 7369 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13035352 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6048469 [patent_doc_number] => 20110207679 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-25 [patent_title] => 'METHODS OF TREATMENT USING IL-16 ANTAGONIST PEPTIDES' [patent_app_type] => utility [patent_app_number] => 13/030201 [patent_app_country] => US [patent_app_date] => 2011-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 9098 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20110207679.pdf [firstpage_image] =>[orig_patent_app_number] => 13030201 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6090466 [patent_doc_number] => 20110218169 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-08 [patent_title] => 'Pirfenidone/Toll-Like Receptor (TLR) Agonist Compounds and Methods of Treating Neutropenia' [patent_app_type] => utility [patent_app_number] => 13/024661 [patent_app_country] => US [patent_app_date] => 2011-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 10347 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0218/20110218169.pdf [firstpage_image] =>[orig_patent_app_number] => 13024661 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8611911 [patent_doc_number] => 20130017224 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-17 [patent_title] => 'Nucleic Acid Molecules Encoding Rantes, and Compositions Comprising and Methods of Using the Same' [patent_app_type] => utility [patent_app_number] => 13/577387 [patent_app_country] => US [patent_app_date] => 2011-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 22630 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13577387 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6164853 [patent_doc_number] => 20110195065 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-11 [patent_title] => 'Compositions and Methods for Diagnosing and Treating Cancer' [patent_app_type] => utility [patent_app_number] => 13/010486 [patent_app_country] => US [patent_app_date] => 2011-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 35828 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0195/20110195065.pdf [firstpage_image] =>[orig_patent_app_number] => 13010486 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8606099 [patent_doc_number] => 20130011411 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-10 [patent_title] => 'METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS, AND TREATMENT OF CANCER' [patent_app_type] => utility [patent_app_number] => 13/520759 [patent_app_country] => US [patent_app_date] => 2011-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 71 [patent_figures_cnt] => 71 [patent_no_of_words] => 23176 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13520759 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6101668 [patent_doc_number] => 20110165160 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-07 [patent_title] => 'NEUTROKINE-ALPHA AND NEUTROKINE-ALPHA SPLICE VARIANT' [patent_app_type] => utility [patent_app_number] => 12/965535 [patent_app_country] => US [patent_app_date] => 2010-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 199558 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20110165160.pdf [firstpage_image] =>[orig_patent_app_number] => 12965535 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11827693 [patent_doc_number] => 09724422 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-08-08 [patent_title] => 'Human lactoferrin derived peptide for use as an antigen masking agent' [patent_app_type] => utility [patent_app_number] => 13/988829 [patent_app_country] => US [patent_app_date] => 2010-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6086 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13988829 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7783876 [patent_doc_number] => 20120045432 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2012-02-23 [patent_title] => 'B LYMPHOCYTE STIMULATOR ASSAYS' [patent_app_type] => utility [patent_app_number] => 12/952091 [patent_app_country] => US [patent_app_date] => 2010-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 199557 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 25 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A9/0045/20120045432.pdf [firstpage_image] =>[orig_patent_app_number] => 12952091 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7783876 [patent_doc_number] => 20120045432 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2012-02-23 [patent_title] => 'B LYMPHOCYTE STIMULATOR ASSAYS' [patent_app_type] => utility [patent_app_number] => 12/952091 [patent_app_country] => US [patent_app_date] => 2010-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 199557 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 25 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A9/0045/20120045432.pdf [firstpage_image] =>[orig_patent_app_number] => 12952091 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8074019 [patent_doc_number] => 20110240012 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-06 [patent_title] => 'RECOMBINANT HUMAN CC10 AND COMPOSITIONS THEREOF FOR USE IN THE TREATMENT OF NASAL RHINITIS' [patent_app_type] => utility [patent_app_number] => 12/945622 [patent_app_country] => US [patent_app_date] => 2010-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10007 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0240/20110240012.pdf [firstpage_image] =>[orig_patent_app_number] => 12945622 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10143339 [patent_doc_number] => 09176147 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-11-03 [patent_title] => 'Detection of B-cell activating factor as a biomarker for antibody mediated rejection in transplant recipients' [patent_app_type] => utility [patent_app_number] => 13/501671 [patent_app_country] => US [patent_app_date] => 2010-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 10 [patent_no_of_words] => 12217 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13501671 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9823345 [patent_doc_number] => 08932829 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-01-13 [patent_title] => 'Recombinant alpha-fetoprotein and compositions thereof' [patent_app_type] => utility [patent_app_number] => 12/925513 [patent_app_country] => US [patent_app_date] => 2010-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 11992 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12925513 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10856952 [patent_doc_number] => 08883145 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-11-11 [patent_title] => 'Methods of treatment with DLL4 antagonists and an anti-hypertensive agent' [patent_app_type] => utility [patent_app_number] => 13/501944 [patent_app_country] => US [patent_app_date] => 2010-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 13624 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13501944 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10169370 [patent_doc_number] => 09200071 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-12-01 [patent_title] => 'Methods of treating cancer using Notch1 and Notch3 antagonists' [patent_app_type] => utility [patent_app_number] => 13/498560 [patent_app_country] => US [patent_app_date] => 2010-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 41 [patent_no_of_words] => 15807 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13498560 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5959529 [patent_doc_number] => 20110183916 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-28 [patent_title] => 'Apo-2 Ligand' [patent_app_type] => utility [patent_app_number] => 12/924163 [patent_app_country] => US [patent_app_date] => 2010-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 27161 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20110183916.pdf [firstpage_image] =>[orig_patent_app_number] => 12924163 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8994530 [patent_doc_number] => 08518412 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-27 [patent_title] => 'Partial peptide of lacritin' [patent_app_type] => utility [patent_app_number] => 13/496437 [patent_app_country] => US [patent_app_date] => 2010-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10357 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13496437 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7776309 [patent_doc_number] => 20120039890 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2012-02-16 [patent_title] => 'METHODS OF TREATMENT USING ANTIBODIES TO NEUTROKINE-ALPHA' [patent_app_type] => utility [patent_app_number] => 12/870548 [patent_app_country] => US [patent_app_date] => 2010-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 162853 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A9/0039/20120039890.pdf [firstpage_image] =>[orig_patent_app_number] => 12870548 [rel_patent_id] =>[rel_patent_doc_number] =>)